Aslan Pharmaceuticals Ltd (NASDAQ: ASLN) made an official announcement that the company has secured a loan. The funds will be used to advance the clinical development of ASLAN003. The same is used for general corporate purposes besides also being used for the potential treatment of autoimmune gastrointestinal and skin diseases […]